Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 101
Filter
1.
Pediatr Obes ; 12(6): 453-461, 2017 12.
Article in English | MEDLINE | ID: mdl-27384496

ABSTRACT

BACKGROUND: An important area of research in childhood obesity is the identification of factors that predict or moderate the responses to obesity intervention programmes, yet few studies have examined the impact of self-esteem and family functioning on obesity treatment outcomes. OBJECTIVES: We sought to determine whether baseline self-esteem and family functioning predicted or moderated childhood obesity intervention outcomes at 6 months. METHODS: From 2009 to 2011, seventy-five 10-16 year old, racially/ethnically diverse obese youths with abnormal glucose tolerance were randomized to 6 months of an intensive family-based obesity lifestyle intervention (Bright Bodies) or routine outpatient Clinic Care. We examined youth self-concept, parent-rated family functioning and 6-month outcomes (youths' glucose tolerance, weight, body mass index and percent fat). We set the significance threshold as P ≤ 0.05 for moderator and predictor analyzes. RESULTS: Having poor family functioning and self-concept scores indicating high anxiety and low self-esteem at baseline predicted poor 6-month outcomes overall (Bright Bodies and Clinic Care groups combined). Additionally, baseline self-esteem and family functioning moderated treatment effects such that Bright Bodies outperformed Clinic Care in youths with low self-esteem and poorly functioning families, whereas youths with high self-esteem and high-functioning families did similarly well with either intervention. DISCUSSION: Our findings suggest intensive family-based lifestyle programmes are particularly beneficial for youth with low self-esteem and poorly functioning families.


Subject(s)
Pediatric Obesity/psychology , Self Concept , Weight Reduction Programs/methods , Adolescent , Body Mass Index , Body Weight , Child , Ethnicity , Female , Humans , Male , Parents , Pediatric Obesity/therapy , Treatment Outcome
2.
Eur J Vasc Endovasc Surg ; 51(1): 90-9, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26602223

ABSTRACT

OBJECTIVES: It is difficult to establish which patients suffering from critical lower limb ischaemia will benefit from revascularization. Risk scores can provide objectivity in decision making. The aim was to design a new risk score (ERICVA) and compare its predictive power with the PREVENT III and Finnvasc scores. METHODS: An observational retrospective study of patients who underwent revascularization (open or endovascular) in Valladolid's University Hospital between 2005 and 2010 was designed. The sample was divided into two subgroups (development and validation subsamples). After univariate analysis followed by a multivariate Cox regression, a number of variables associated with death and/or major amputation were selected, creating a weighed score called ERICVA, and a simplified version of it. The area under the curve (AUC) of receiver operating characteristic (ROC) curve analysis was performed and the AUC of these two scores were additionally compared with the AUC of the PREVENT III and Finnvasc scales. RESULTS: Six hundred and seventy two cases with an average surveillance of 778 days were included in the study. Amputation free survival (AFS) was 84.8% at 30 days and 63.1% at 1 year. Variables associated with death and/or major amputation in the Cox regression were cerebrovascular disease, prior contralateral major amputation, diabetes mellitus, dialysis, chronic obstructive pulmonary disease, cancer, haematocrit less than 30%, neutrophil/lymphocyte ratio exceeding 5, absence of arterial Doppler signal at the ankle, emergency admission, and Rutherford stage 6; these variables were used for the ERICVA and simplified ERICVA score designs. Scores were applied to both subsamples; in the development sample the AUC of ERICVA and simplified ERICVA was significantly higher than the PREVENT III (p = .008 and p = .045) and Finnvasc (p < .0001 and p = .0013) scores; in the validation sample the AUC of ERICVA and simplified ERICVA were significantly higher than Finnvasc score (p = .0323 and p = .0017). CONCLUSIONS: The ERICVA model has a good predictive capacity for death and/or major amputation in the clinical setting, and is better than the PREVENT III and Finnvasc scores.


Subject(s)
Critical Illness , Decision Support Techniques , Endovascular Procedures , Ischemia/therapy , Lower Extremity/blood supply , Vascular Surgical Procedures , Aged , Aged, 80 and over , Amputation, Surgical , Area Under Curve , Comorbidity , Disease-Free Survival , Endovascular Procedures/adverse effects , Endovascular Procedures/mortality , Female , Hospitals, University , Humans , Ischemia/diagnosis , Ischemia/mortality , Ischemia/physiopathology , Kaplan-Meier Estimate , Limb Salvage , Male , Middle Aged , Multivariate Analysis , Patient Selection , Predictive Value of Tests , Proportional Hazards Models , ROC Curve , Reproducibility of Results , Retrospective Studies , Risk Assessment , Risk Factors , Spain , Treatment Outcome , Vascular Surgical Procedures/adverse effects , Vascular Surgical Procedures/mortality
5.
Rev. esp. investig. quir ; 16(1): 32-36, ene.-mar. 2013. ilus, tab
Article in Spanish | IBECS | ID: ibc-111015

ABSTRACT

La ATP de las arterias infrapoplíteos es una técnica segura, con una morbimortalidad perioperatoria baja. La ATP puede ser considerada la terapia inicial para los pacientes con isquemia crítica de extremidades inferiores. En este sector, la clasificación ASC es útil como herramienta pronostica pero ha resultado inútil para decidir si el tratamiento más adecuado es endovascular o quirúrgico abierto. De tal forma, se ha llegado a recomendar que la indicación de cirugía abierta no se base en criterios angiográficos si no en criterios clínicos del paciente, reservándola para pacientes con bajo riesgo quirúrgico, un buen flujo de salida a nivel del pie y una adecuada vena safena interna. Las estrategias basadas en la arteria relacionada con la herida o la úlcera (angiosomas), se incrementan las posibilidades de cura de las lesiones isquémicas en tobillo y pie (AU)


PTA of infrapopliteal arteries is a safe technique, with low periprocedural morbimortality. PTA is the initial therapy in patients with critical ischemia of the limbs. In the infrapopliteal area, the TASC classification is an useful prognostic tool, but it results useless to decide between endovascular techniques or open surgical repair. The guidelines for revascularization should be based on clinical criteria, not on angiographic findings. Surgery could be indicated in patients with low surgical risk, good run-off in the foot, and good saphenous vein. The strategies based on wound or ulcer related artery (angiosomes) increase the health possibilities of the ischemic lesions in ankle and foot (AU)


Subject(s)
Humans , Popliteal Artery/surgery , Endovascular Procedures/methods , Ischemia/surgery , Peripheral Vascular Diseases/surgery
6.
Theor Appl Genet ; 108(4): 681-7, 2004 Feb.
Article in English | MEDLINE | ID: mdl-14586503

ABSTRACT

The inheritance of shoot regeneration through shoot-tip meristem culture derived from maize seedling was evaluated, and the markers (RAPD and SSR) associated with this regeneration character were identified both in a group of North American maize inbreds and a crossing population. A discrete distribution of percent regeneration and no. of shoots per explant was observed in the inbred group and the F(2) population. The results suggested that this regenerable trait was controlled by several major genes. Five RAPD markers were identified to be relevant to percent regeneration in maize shoot-tip culture system. One RAPD marker and three SSR markers were associated with no. of shoot per explant and its relevant traits. Of them marker BC603-1600 explained 18% of the variation for no. of shoot per explant and 16% of the variation for callus size. The BC603-1600 was sequenced and assigned in linkage group 7 based on a NCBI blast search. The information provided here should benefit to determine the genetic mechanisms involved in the maize regeneration response related to shoot meristem culture pathway and benefit to select high regenerable germplasm by using marker assisted selection.


Subject(s)
Meristem/physiology , Regeneration/genetics , Seeds/physiology , Zea mays/genetics , Zea mays/physiology , Analysis of Variance , Chromosome Mapping , Electrophoresis, Agar Gel , Meristem/genetics , Minisatellite Repeats/genetics , North America , Random Amplified Polymorphic DNA Technique , Seeds/genetics
7.
Phytopathology ; 93(6): 712-9, 2003 Jun.
Article in English | MEDLINE | ID: mdl-18943058

ABSTRACT

ABSTRACT The relationship between the primary cell wall phenolic acids, dehydrodimers of ferulic acid, and maize grain resistance to Fusarium graminearum, the causal agent of gibberella ear rot, was investigated. Concentrations of dehydrodimers of ferulic acid were determined in the pericarp and aleurone tissues of five inbreds and two hybrids of varying susceptibility and in a segregating population from a cross between a resistant and susceptible inbred. Significant negative correlations were found between disease severity and diferulic acid content. Even stronger correlations were observed between diferulic acid and the fungal steroid ergosterol, which is an indicator of fungal biomass in infected plant tissue. These results were consistent over two consecutive field seasons, which differed significantly for temperature and rainfall during pollination, the most susceptible stage of ear development. No correlation was found between the levels of these phenolics and deoxynivalenol levels. This is the first report of in vivo evidence that the dehydrodimers of ferulic acid content in pericarp and aleurone tissues may play a role in genotypic resistance of maize to gibberella ear rot.

8.
Symp Ser Soc Appl Microbiol ; (31): 111S-120S, 2002.
Article in English | MEDLINE | ID: mdl-12481836

ABSTRACT

AIMS: The aims of the project were threefold: to survey the use of disinfectants in the UK food industry; to assess the product and environmental microflora of selected food factories for the persistence of Listeria monocytogenes and Escherichia coli; and to determine the disinfectant resistance of any persistent strains. METHODS AND RESULTS: A survey of the use of disinfectants in the UK food industry was undertaken in which a total of 40 sites were visited and a further 77 postal questionnaires were returned from farms, food manufacture, food transport and food retail sites. Quaternary ammonium compounds (QACs) were predominantly used, applied in small volumes as a mist. Approximately 30,000 samples from the product and environment of five chilled food factories were examined for L. monocytogenes and E. coli over a 3 year period. A total of 181 L. monocytogenes and 176 E. coli isolates were ribotyped to yield 19 and 34 ribogroups, respectively. Some strains were isolated only from the product, a number only from the environment and others from both niches. Some strains were seen to be persistent for the duration of the sampling exercise (2-3 years). The most common L. monocytogenes and E. coli strains, together with two environmental L. monocytogenes strains, were assessed for any resistance to commercial disinfectants as compared with a laboratory L. monocytogenes disinfectant testing strain. The resistance of the L. monocytogenes and E. coli strains isolated from the factory were not significantly different from the laboratory control strain. CONCLUSIONS: Persistent strains of L. monocytogenes and E. coli are found in the UK food industry, though this persistence is not related to their increased susceptibility to the most commonly used disinfectants. SIGNIFICANCE AND IMPACT OF THE STUDY: The concept of a persistent microflora in food factories will have an impact on the future selection of suitable control options, including the use of biocides.


Subject(s)
Anti-Bacterial Agents/pharmacology , Disinfectants/pharmacology , Drug Resistance, Bacterial , Escherichia coli/drug effects , Food Industry/standards , Listeria monocytogenes/drug effects , Microbial Sensitivity Tests
9.
J Appl Microbiol ; 92 Suppl: 111S-20S, 2002.
Article in English | MEDLINE | ID: mdl-12000620

ABSTRACT

AIMS: The aims of the project were threefold: to survey the use of disinfectants in the UK food industry; to assess the product and environmental microflora of selected food factories for the persistence of Listeria monocytogenes and Escherichia coli; and to determine the disinfectant resistance of any persistent strains. METHODS AND RESULTS: A survey of the use of disinfectants in the UK food industry was undertaken in which a total of 40 sites were visited and a further 77 postal questionnaires were returned from farms, food manufacture, food transport and food retail sites. Quaternary ammonium compounds (QACs) were predominantly used, applied in small volumes as a mist. Approximately 30,000 samples from the product and environment of five chilled food factories were examined for L. monocytogenes and E. coli over a 3 year period. A total of 181 L. monocytogenes and 176 E. coli isolates were ribotyped to yield 19 and 34 ribogroups, respectively. Some strains were isolated only from the product, a number only from the environment and others from both niches. Some strains were seen to be persistent for the duration of the sampling exercise (2-3 years). The most common L. monocytogenes and E. coli strains, together with two environmental L. monocytogenes strains, were assessed for any resistance to commercial disinfectants as compared with a laboratory L. monocytogenes disinfectant testing strain. The resistance of the L. monocytogenes and E. coli strains isolated from the factory were not significantly different from the laboratory control strain. CONCLUSIONS: Persistent strains of L. monocytogenes and E. coli are found in the UK food industry, though this persistence is not related to their increased susceptibility to the most commonly used disinfectants. SIGNIFICANCE AND IMPACT OF THE STUDY: The concept of a persistent microflora in food factories will have an impact on the future selection of suitable control options, including the use of biocides.


Subject(s)
Disinfectants/pharmacology , Drug Resistance, Bacterial , Escherichia coli/drug effects , Food Industry , Food Microbiology , Listeria monocytogenes/drug effects , DNA Fingerprinting , DNA, Bacterial/analysis , Data Collection , Equipment Contamination , Escherichia coli/genetics , Humans , Listeria monocytogenes/genetics , United Kingdom
10.
N Z Vet J ; 50(3 Suppl): 64-6, 2002.
Article in English | MEDLINE | ID: mdl-16032241
11.
Lancet ; 358(9285): 929-30, 2001 Sep 15.
Article in English | MEDLINE | ID: mdl-11575379
12.
J Appl Microbiol ; 89(6): 910-9, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11123464

ABSTRACT

A finger rinse technique for counting micro-organisms on hands showed no significant difference in the level of recovered micro-organisms following hand drying using either warm air or paper towels. Contact plate results appeared to reflect the degree of dampness of hands after drying rather than the actual numbers of micro-organisms on the hands. In laboratory tests, a reduction in airborne count of Pseudomonas aeruginosa and Staphylococcus aureus of between 40 and 75% was achieved from 600 readings comparing inlets and outlets of warm air hand driers. In washroom trials, the number of airborne micro-organisms was reduced by between 30 and 75%. Air emitted from the outlet of the driers contained significantly fewer micro-organisms than air entering the driers. Drying of hands with hand driers was no more likely to generate airborne micro-organisms than drying with paper towels. Levels of micro-organisms on external surfaces of hand driers were not significantly different to those on other washroom surfaces. This work shows that warm air hand driers, of the type used in this study, are a hygienic method of drying hands and therefore appropriate for use in both the healthcare and food industry.


Subject(s)
Air Microbiology , Bacteria/isolation & purification , Equipment Contamination , Hand Disinfection , Hand/microbiology , Hot Temperature , Colony Count, Microbial , Humans , Paper , Pseudomonas aeruginosa/isolation & purification , Skin/microbiology , Staphylococcus aureus/isolation & purification
13.
Pediatr Nephrol ; 15(1-2): 31-2, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11095007

ABSTRACT

We report the first case of Pasteurella pneumotropica peritonitis in a peritoneal dialysis patient. This rare infection was the result of contamination of the dialysis tubing by a pet hamster. We stress the importance of household pets as a source of infection in the peritoneal dialysis population.


Subject(s)
Kidney Failure, Chronic/complications , Pasteurella Infections/complications , Peritoneal Dialysis , Peritonitis/complications , Animals , Animals, Domestic , Bites and Stings , Child , Cricetinae , Hemolytic-Uremic Syndrome/complications , Humans , Kidney Failure, Chronic/therapy , Male , Mesocricetus , Pasteurella Infections/etiology
14.
Br J Anaesth ; 85(2): 211-6, 2000 Aug.
Article in English | MEDLINE | ID: mdl-10992826

ABSTRACT

We studied the effect of tramadol on the ventilatory response to 7 min acute isocapnic hypoxia (SpO2 85.1 (SD 0.4)%) during steady mild hypercapnia (PE'CO2 0.7 kPa above normoxic baseline) in 14 healthy volunteers (seven male). The acute hypoxic response was measured before and 1 h after oral placebo or tramadol (100 mg). After tramadol, ventilation during mild hypercapnia (mean 11.28 litres min-1) was significantly less (P < 0.05) than during placebo baseline (13.93 litres min-1), tramadol baseline (14.63 litres min-1), or after placebo (14.95 litres min-1), confirming that tramadol has a small depressive effect on the hypercapnic ventilatory response. There was no significant difference in the hypoxic ventilation/SpO2 response (1 min-1 %-1) measured during the placebo baseline (0.99), placebo (1.18), tramadol baseline (0.78) or tramadol (0.68) runs. These data suggest that tramadol does not depress the hypoxic ventilatory response.


Subject(s)
Analgesics, Opioid/therapeutic use , Hypercapnia/drug therapy , Hypoxia/drug therapy , Respiration/drug effects , Tramadol/therapeutic use , Adolescent , Adult , Cross-Over Studies , Female , Humans , Male
15.
J Appl Microbiol ; 87(5): 718-25, 1999 Nov.
Article in English | MEDLINE | ID: mdl-10594713

ABSTRACT

A number of proprietary disinfectant products (18) used in the food industry were tested for their bactericidal efficacy against Pseudomonas aeruginosa and Escherichia coli O157:H7 at 20 and 10 degrees C according to the BS EN 1276 (1997) quantitative suspension test for the evaluation of bactericidal activity of chemical disinfectants and antiseptics used in food, industrial, domestic and institutional areas. At 20 degrees C, 13 products passed at their in-use concentration (under clean and dirty conditions) against Ps. aeruginosa and 15 passed against E. coli O157:H7. The number of products passing the test at 10 degrees C was 11 and 14 for Ps. aeruginosa and E. coli O157:H7, respectively. The products exhibiting reduced efficacy at the lower temperature were amphoterics and quaternary ammonium compounds although some of these types of products were effective at both temperatures. Products that passed against Ps. aeruginosa generally also passed against E. coli O157:H7. Taking all the results together, only 11 of the total of 18 products achieved a pass result under all the parameters tested. This work demonstrates the need for final verification of disinfectant efficacy by undertaking field trials in the food-processing environment in which the product is intended for use.


Subject(s)
Disinfectants/pharmacology , Escherichia coli O157/drug effects , Pseudomonas aeruginosa/drug effects , Cold Temperature , Escherichia coli O157/growth & development , Evaluation Studies as Topic , Food Technology , Pseudomonas aeruginosa/growth & development
16.
J Appl Microbiol ; 87(1): 41-8, 1999 Jul.
Article in English | MEDLINE | ID: mdl-10432586

ABSTRACT

The effectiveness of cleaning was investigated through food factory trials and laboratory experiments using a naturally occurring biofilm from a food factory environment and generated biofilms. The efficacy of factory cleaning and disinfection programmes was assessed by swabbing and total viable count (TVC) analysis of surfaces before cleaning, after cleaning and after disinfection. Cleaning produced a 0.91 log reduction in the attached population. Investigation of the effectiveness of a variety of cleaning methods in the removal of a naturally occurring food factory biofilm showed that the high pressure spray and the mechanical floor scrubber, which use a high degree of mechanical action, were most effective. Cleaning trials with biofilms of Pseudomonas aeruginosa or Staphylococcus aureus showed that spraying with water at pressures of 34.5, 51.7 and 68.9 bar did not significantly increase the removal, as assessed by direct epifluorescent microscopy (DEM) and swabbing and TVC analysis, beyond the three log reduction observed at 17.2 bar. The effect of spray time at 17.2 bar showed that increasing spray time from 1 to 10 s did not significantly increase removal of Ps. aeruginosa biofilm. Investigation of the optimum distance of the spray lance from the surface at 17.2 bar was found to be between 125 and 250 mm. The use of an alkaline, acidic or neutral detergent prior to spraying with water at 17.2 bar did not significantly increase the removal of Ps. aeruginosa or Staph. aureus. However, the acidic and alkaline products significantly (P = 0.05) affected the viability of Staph. aureus and Ps. aeruginosa, respectively, thereby minimizing the potential for the spread of contamination.


Subject(s)
Biofilms , Disinfection/methods , Food-Processing Industry/standards , Bacterial Adhesion , Colony Count, Microbial , Detergents , Microscopy, Fluorescence , Pressure , Pseudomonas aeruginosa/growth & development , Staphylococcus aureus/growth & development , Water
17.
J S Afr Vet Assoc ; 70(4): 172-6, 1999 Dec.
Article in English | MEDLINE | ID: mdl-10855844

ABSTRACT

Therapeutic drug monitoring is an underutilised resource in the management of canine primary epilepsy. Many of the anti-epileptic drugs, including phenobarbitone, have variable pharmacokinetic profiles in different dogs, with each individual animal showing variable rates of absorption, distribution, metabolism and excretion. This results in variable serum drug concentrations with the same oral dose. Many clinicians interpret this situation as therapeutic failure and classify these patients as refractory to treatment. By measuring blood concentrations of drugs at appropriate times, it is possible to explain the efficacy or failure of treatment, and also to prevent serum concentrations from reaching toxic levels. By analysing paired samples, key pharmacokinetic parameters may be calculated for each patient and a profile for the disposition of the drug obtained. Individual optimal drug dosage can be calculated for each patient at little cost to the pet owner.


Subject(s)
Anticonvulsants/therapeutic use , Bromides/therapeutic use , Dog Diseases/drug therapy , Drug Monitoring , Epilepsy/veterinary , Phenobarbital/therapeutic use , Potassium Compounds/therapeutic use , Animals , Anticonvulsants/pharmacokinetics , Bromides/pharmacokinetics , Dog Diseases/blood , Dogs , Drug Therapy, Combination , Epilepsy/classification , Epilepsy/drug therapy , Phenobarbital/pharmacokinetics , Potassium Compounds/pharmacokinetics
19.
J S Afr Vet Assoc ; 68(1): 21-5, 1997 Mar.
Article in English | MEDLINE | ID: mdl-9186936

ABSTRACT

Osteoarthritis or degenerative joint disease is a condition characterised by degeneration of articular cartilage often associated with the formation of new bone at joint surfaces on margins. Commonly encountered in dogs, osteoarthritis may have a gradual onset, but may also occur acutely. Osteoarthritis can be a primary disease of joint cartilage, but is more after secondary to abnormal stresses on joints. This article describes the pathogenesis and progression of cartilage degeneration as well as the dietary, lifestyle and pharmacological management of osteoarthritis. Recent pharmacological developments allow the clinician not only to control clinical signs of the disease, but also to slow the progression of cartilage degeneration.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Anti-Inflammatory Agents/therapeutic use , Dog Diseases/drug therapy , Osteoarthritis/veterinary , Animals , Cartilage, Articular/physiopathology , Complementary Therapies/veterinary , Dog Diseases/physiopathology , Dogs , Exercise Therapy , Glycosaminoglycans/therapeutic use , Osteoarthritis/drug therapy , Osteoarthritis/physiopathology , Steroids , Weight Loss
20.
J S Afr Vet Assoc ; 68(4): 111-3, 1997 Dec.
Article in English | MEDLINE | ID: mdl-9561493

ABSTRACT

A clinical trial was designed to evaluate the effects of diminazene aceturate and its stabiliser antipyrine on serum pseudocholinesterase (PChE) and red blood cell acetylcholinesterase (RBC AChE) in dogs with babesiosis. The trial was conducted on naturally occurring, uncomplicated cases of babesiosis (n = 20) that were randomly allocated to groups receiving a standard therapeutic dose of diminazene aceturate with antipyrine stabiliser (n = 10) or antipyrine alone (n = 10). Blood was drawn immediately before and every 15 minutes for 1 hour after treatment. Plasma PChE showed a 4% decrease between 0 and 60 min within the treatment group (p < 0.05). No statistically significant differences were found between the treatment and control groups at any of the time intervals for PChE. There was an increase in RBC AChE activity at 15 min in the treatment group (p < 0.05). No significant differences were found between the treatment and control groups at any time interval for RBC AChE. In view of the difference in PChE, samples from additional, new cases (n = 10) of canine babesiosis were collected to identify the affect of the drug over 12 hours. No significant depression was identified over this time interval. The results suggests that the underlying mechanism in producing side-effects, when they do occur, is unlikely to be through cholinesterase depression.


Subject(s)
Acetylcholinesterase/drug effects , Antiprotozoal Agents/pharmacology , Antipyrine/pharmacology , Babesiosis/drug therapy , Butyrylcholinesterase/drug effects , Diminazene/analogs & derivatives , Dog Diseases/drug therapy , Acetylcholinesterase/blood , Animals , Babesiosis/enzymology , Butyrylcholinesterase/blood , Diminazene/pharmacology , Dog Diseases/enzymology , Dogs , Erythrocytes/enzymology , Random Allocation
SELECTION OF CITATIONS
SEARCH DETAIL
...